Charles G Cochrane, M.D. - Publications

Affiliations: 
1961- Immunology and Microbiology Scripps Research Institute 
Area:
Molecular Mechanisms of Inflammatory Injury, Development of a Synthetic Peptide Pulmonary Surfactant for Use in Infant and Adult Human Beings
Website:
https://www.scripps.edu/faculty/cochrane/

74 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
1998 COCHRANE CG, WEIGLE WO, DIXON FJ. The role of polymorphonuclear leukocytes in the initiation and cessation of the Arthus vasculitis. The Journal of Experimental Medicine. 110: 481-94. PMID 13810816 DOI: 10.1084/Jem.110.3.481  0.523
1998 COCHRANE CG, WEIGLE WO, DIXON FJ. Factors responsible for decline of inflammation in Arthus hypersensitivity vasculitis. Proceedings of the Society For Experimental Biology and Medicine. Society For Experimental Biology and Medicine (New York, N.Y.). 101: 695-9. PMID 13810815 DOI: 10.3181/00379727-101-25065  0.52
1997 Quehenberger O, Pan ZK, Prossnitz ER, Cavanagh SL, Cochrane CG, Ye RD. Identification of an N-formyl peptide receptor ligand binding domain by a gain-of-function approach Biochemical and Biophysical Research Communications. 238: 377-381. PMID 9299516 DOI: 10.1006/Bbrc.1997.7298  0.507
1996 COCHRANE CG, UNANUE ER, DIXON FJ. A ROLE OF POLYMORPHONUCLEAR LEUKOCYTES AND COMPLEMENT IN NEPHROTOXIC NEPHRITIS. The Journal of Experimental Medicine. 122: 99-116. PMID 14330416 DOI: 10.1084/Jem.122.1.99  0.502
1993 Schreiber RE, Prossnitz ER, Ye RD, Cochrane CG, Jesaitis AJ, Bokoch GM. Reconstitution of recombinant N-formyl chemotactic peptide receptor with G protein Journal of Leukocyte Biology. 53: 470-474. PMID 8482927 DOI: 10.1002/Jlb.53.4.470  0.528
1993 Prossnitz ER, Quehenberger O, Cochrane CG, Ye RD. The role of the third intracellular loop of the neutrophil N-formyl peptide receptor in G protein coupling. The Biochemical Journal. 294: 581-7. PMID 8373373 DOI: 10.1042/Bj2940581  0.52
1992 Ye RD, Cavanagh SL, Quehenberger O, Prossnitz ER, Cochrane CG. Isolation of a cDNA that encodes a novel granulocyte N-formyl peptide receptor Biochemical and Biophysical Research Communications. 184: 582-589. PMID 1374236 DOI: 10.1016/0006-291X(92)90629-Y  0.529
1991 Cochrane CG. Mechanisms of oxidant injury of cells. Molecular Aspects of Medicine. 12: 137-147. PMID 2072822 DOI: 10.1016/0098-2997(91)90009-B  0.308
1991 Cochrane CG. Cellular injury by oxidants The American Journal of Medicine. 91: 177-188. PMID 1928208 DOI: 10.1016/0002-9343(91)90280-B  0.304
1991 Revak SD, Merritt TA, Hallman M, Heldt G, La Polla RJ, Hoey K, Houghten RA, Cochrane CG. The use of synthetic peptides in the formation of biophysically and biologically active pulmonary surfactants. Pediatric Research. 29: 460-5. PMID 1896249 DOI: 10.1203/00006450-199105010-00010  0.303
1991 Prossnitz ER, Quehenberger O, Cochrane CG, Ye RD. Transmembrane signalling by the N-formyl peptide receptor in stably transfected fibroblasts. Biochemical and Biophysical Research Communications. 179: 471-6. PMID 1883372 DOI: 10.1016/0006-291X(91)91394-R  0.532
1991 Ye RD, Prossnitz ER, Zou AH, Cochrane CG. Characterization of a human cDNA that encodes a functional receptor for platelet activating factor. Biochemical and Biophysical Research Communications. 180: 105-11. PMID 1656963 DOI: 10.1016/S0006-291X(05)81261-6  0.537
1990 Schraufstätter IU, Browne K, Harris A, Hyslop PA, Jackson JH, Quehenberger O, Cochrane CG. Mechanisms of hypochlorite injury of target cells. The Journal of Clinical Investigation. 85: 554-62. PMID 2153710 DOI: 10.1172/Jci114472  0.335
1989 Christiansen SC, Zuraw BL, Proud D, Cochrane CG. Inhibition of human bronchial kallikrein in asthma. The American Review of Respiratory Disease. 139: 1125-31. PMID 2785358 DOI: 10.1164/Ajrccm/139.5.1125  0.302
1988 Peters JH, Ginsberg MH, Case CM, Cochrane CG. Release of soluble fibronectin containing an extra type III domain (ED1) during acute pulmonary injury mediated by oxidants or leukocytes in vivo American Review of Respiratory Disease. 138: 167-174. PMID 3202394 DOI: 10.1164/Ajrccm/138.1.167  0.319
1988 Schraufstätter IU, Hyslop PA, Jackson J, Cochrane CG. Cellular Targets of H 2 O 2 and HOCl Induced Injury Basic Life Sciences. 49: 833-837. PMID 2855006 DOI: 10.1007/978-1-4684-5568-7_134  0.311
1988 Cochrane CG. Alpha-1-proteinase inhibitor in inflammatory states of humans and laboratory animals The American Journal of Medicine. 84: 75-79. DOI: 10.1016/S0002-9343(88)80074-3  0.303
1987 Christiansen SC, Proud D, Cochrane CG. Detection of tissue kallikrein in the bronchoalveolar lavage fluid of asthmatic subjects. The Journal of Clinical Investigation. 79: 188-97. PMID 3540008 DOI: 10.1172/Jci112782  0.338
1987 Schraufstätter IU, Hyslop PA, Jackson J, Revak SD, Cochrane CG. Biochemical events associated with pulmonary failure in shock and trauma. Journal of Burn Care & Rehabilitation. 8: 536-542. DOI: 10.1097/00004630-198708060-00016  0.309
1986 Peters JH, Ginsberg MH, Bohl BP, Sklar LA, Cochrane CG. Intravascular release of intact cellular fibronectin during oxidant-induced injury of the in vitro perfused rabbit lung Journal of Clinical Investigation. 78: 1596-1603. PMID 3023447 DOI: 10.1172/Jci112752  0.337
1986 Schraufstatter IU, Hyslop PA, Hinshaw DB, Spragg RG, Sklar LA, Cochrane CG. Hydrogen peroxide-induced injury of cells and its prevention by inhibitors of poly(ADP-ribose) polymerase. Proceedings of the National Academy of Sciences of the United States of America. 83: 4908-12. PMID 2941760 DOI: 10.1073/Pnas.83.13.4908  0.32
1986 Schraufstatter IU, Hinshaw DB, Hyslop PA, Spragg RG, Cochrane CG. Oxidant injury of cells. DNA strand-breaks activate polyadenosine diphosphate-ribose polymerase and lead to depletion of nicotinamide adenine dinucleotide. Journal of Clinical Investigation. 77: 1312-1320. PMID 2937805 DOI: 10.1172/Jci112436  0.305
1985 Schraufstatter IU, Hinshaw DB, Hyslop PA, Spragg RG, Cochrane CG. Glutathione cycle activity and pyridine nucleotide levels in oxidant-induced injury of cells. Journal of Clinical Investigation. 76: 1131-1139. PMID 3840176 DOI: 10.1172/Jci112068  0.317
1985 Jesaitis AJ, Tolley JO, Painter RG, Sklar LA, Cochrane CG. Membrane-cytoskeleton interactions and the regulation of chemotactic peptide-induced activation of human granulocytes: The effects of dihydrocytochalasin B Journal of Cellular Biochemistry. 27: 241-253. PMID 3838753 DOI: 10.1002/Jcb.240270306  0.345
1985 Revak SD, Rice CL, Schraufstätter IU, Halsey WA, Bohl BP, Clancy RM, Cochrane CG. Experimental pulmonary inflammatory injury in the monkey. The Journal of Clinical Investigation. 76: 1182-92. PMID 2995448 DOI: 10.1172/Jci112074  0.335
1985 Cochrane CG, Schraufstätter IU, Hinshaw DB, Hyslop PA, Spragg RG, Sklar LA. Atp In Oxidant-Induced Tissue Injury: 35 Pediatric Research. 19: 749-749. DOI: 10.1203/00006450-198507000-00055  0.303
1984 Schraufstätter IU, Revak SD, Cochrane CG. Proteases and oxidants in experimental pulmonary inflammatory injury. Journal of Clinical Investigation. 73: 1175-1184. PMID 6368592 DOI: 10.1172/Jci111303  0.339
1984 Jesaitis AJ, Naemura JR, Sklar LA, Cochrane CG, Painter RG. Rapid modulation of N-formyl chemotactic peptide receptors on the surface of human granulocytes: Formation of high-affinity ligand-receptor complexes in transient association with cytoskeleton Journal of Cell Biology. 98: 1378-1387. PMID 6325470 DOI: 10.1083/Jcb.98.4.1378  0.317
1984 Hyslop PA, Oades ZG, Jesaitis AJ, Painter RG, Cochrane CG, Sklar LA. Evidence for N-formyl chemotactic peptide-stimulated GTPase activity in human neutrophil homogenates Febs Letters. 166: 165-169. PMID 6141069 DOI: 10.1016/0014-5793(84)80065-4  0.338
1984 Hojima Y, Cochrane C, Wiggins R, Austen K, Stevens R. In vitro activation of the contact (Hageman factor) system of plasma by heparin and chondroitin sulfate E. Blood. 63: 1453-1459. DOI: 10.1182/Blood.V63.6.1453.1453  0.354
1983 Meier HL, Kaplan AP, Lichtenstein LM, Revak S, Cochrane CG, Newball HH. Anaphylactic release of a prekallikrein activator from human lung in vitro. Journal of Clinical Investigation. 72: 574-581. PMID 6192147 DOI: 10.1172/Jci111005  0.333
1982 Mcguire WW, Spragg RG, Cohen AB, Cochrane CG. Studies on the Pathogenesis of the Adult Respiratory Distress Syndrome Journal of Clinical Investigation. 69: 543-553. PMID 7037851 DOI: 10.1172/Jci110480  0.316
1982 Painter RG, Schmitt M, Jesaitis AJ, Sklar LA, Preissner K, Cochrane CG. Photoaffinity labeling of the N-formyl peptide receptor of human polymorphonuclear leukocytes Journal of Cellular Biochemistry. 20: 203-214. PMID 6302117 DOI: 10.1002/Jcb.240200211  0.325
1982 Sklar LA, Jesaitis AJ, Painter RG, Cochrane CG. Ligand/receptor internalization: A spectroscopic analysis and a comparison of ligand binding, cellular response, and internalization by human neutrophils Journal of Cellular Biochemistry. 20: 193-202. PMID 6302116 DOI: 10.1002/Jcb.240200210  0.305
1982 Jesaitis AJ, Naemura JR, Painter RG, Schmitt M, Sklar LA, Cochrane CG. The fate of the N-formyl-chemotactic peptide receptor in stimulated human granulocytes: Subcellular fractionation studies Journal of Cellular Biochemistry. 20: 177-191. PMID 6302115 DOI: 10.1002/Jcb.240200209  0.322
1982 Cochrane CG, Griffin JH. The biochemistry and pathophysiology of the contact system of plasma. Advances in Immunology. 33: 241-306. PMID 6182767 DOI: 10.1016/S0065-2776(08)60837-8  0.305
1982 Jesaitis AJ, Naemura JR, Painter RG, Sklar LA, Cochrane CG. Intracellular localization of N-formyl chemotactic receptor and Mg2+ dependent ATPase in human granulocytes Bba - General Subjects. 719: 556-568. PMID 6129903 DOI: 10.1016/0304-4165(82)90246-X  0.306
1981 Sklar LA, Oades ZG, Jesaitis AJ, Painter RG, Cochrane CG. Fluoresceinated chemotactic peptide and high-affinity antifluorescein antibody as a probe of the temporal characteristics of neutrophil stimulation Proceedings of the National Academy of Sciences of the United States of America. 78: 7540-7544. PMID 7038681 DOI: 10.1073/Pnas.78.12.7540  0.316
1981 Wiggins RC, Cochrane CG. Immune-Complex-Mediated Biologic Effects The New England Journal of Medicine. 304: 518-520. PMID 6450327 DOI: 10.1056/Nejm198102263040904  0.304
1980 Curd JG, Prograis LJ, Cochrane CG. Detection of active kallikrein in induced blister fluids of hereditary angioedema patients. Journal of Experimental Medicine. 152: 742-747. PMID 6902743 DOI: 10.1084/Jem.152.3.742  0.335
1980 Wiggins RC, Loskutoff DJ, Cochrane CG, Griffin JH, Edgington TS. Activation of rabbit Hageman factor by homogenates of cultured rabbit endothelial cells. The Journal of Clinical Investigation. 65: 197-206. PMID 6444222 DOI: 10.1172/Jci109651  0.551
1979 Wiggins RC, Cochrane CG, Griffin JH. Rabbit blood coagulation factor XI. Mechanism of activation of rabbit Hageman factor (factor XII). Thrombosis Research. 15: 487-95. PMID 494157 DOI: 10.1016/0049-3848(79)90154-3  0.328
1979 Wiggins RC, Cochrane CG, Griffin JH. Rabbit blood coagulation factor XI. Purification and properties. Thrombosis Research. 15: 475-86. PMID 494156 DOI: 10.1016/0049-3848(79)90153-1  0.313
1979 Cochrane CG, Griffin JH. Molecular assembly in the contact phase of the Hageman factor system. The American Journal of Medicine. 67: 657-64. PMID 386794 DOI: 10.1016/0002-9343(79)90253-5  0.307
1978 Revak SD, Cochrane CG, Bouma BN, Griffin JH. Surface and fluid phase activities of two forms of activated Hageman factor produced during contact activation of plasma. The Journal of Experimental Medicine. 147: 719-29. PMID 632748 DOI: 10.1084/Jem.147.3.719  0.302
1978 Wiggins RC, Bouma BN, Cochrane CG, Griffin JH. Role of high-molecular-weight kininogen in surface-binding and activation of coagulation Factor XI and prekallikrein. Proceedings of the National Academy of Sciences of the United States of America. 74: 4636-40. PMID 270705 DOI: 10.1073/Pnas.74.10.4636  0.32
1978 Cochrane CG. Mediating systems in inflammatory disease. Journal of Investigative Dermatology. 71: 40-48. PMID 150452 DOI: 10.1111/1523-1747.Ep12543931  0.306
1977 Revak SD, Cochrane CG, Griffin JH. The binding and cleavage characteristics of human Hageman factor during contact activation. A comparison of normal plasma with plasmas deficient in factor XI, prekallikrein, or high molecular weight kininogen. The Journal of Clinical Investigation. 59: 1167-75. PMID 864009 DOI: 10.1172/Jci108741  0.318
1977 Cochrane CG. Role of granulocytes in immune complex-induced tissue injuries. Inflammation. 2: 319-333. PMID 154471 DOI: 10.1007/Bf00921011  0.346
1976 Griffin JH, Cochrane CG. Mechanisms for the involvement of high molecular weight kininogen in surface-dependent reactions of Hageman factor. Proceedings of the National Academy of Sciences of the United States of America. 73: 2554-8. PMID 1066663 DOI: 10.1073/Pnas.73.8.2554  0.316
1976 Griffin JH, Cochrane CG. [7] Human factor XII (Hageman factor) Methods in Enzymology. 45: 56-65. PMID 1012017 DOI: 10.1016/S0076-6879(76)45009-7  0.322
1976 Morrison DC, Henson PM, Roser JF, Cochrane CG. Two Independent Recognition Sites for the Initiation of Histamine Release from Mast Cells Leukocyte Membrane Determinants Regulating Immune Reactivity. 551-562. DOI: 10.1016/B978-0-12-233750-5.50105-6  0.331
1975 Morrison DC, Roser JF, Cochrane CG, Henson PM. Two distinct mechanisms for the initiation of mast cell Degranulation International Archives of Allergy and Immunology. 49: 172-178. PMID 166931 DOI: 10.1159/000231392  0.319
1974 Morrison DC, Cochrane CG. Direct evidence for Hageman factor (factor XII) activation by bacterial lipopolysaccharides (endotoxins) Journal of Experimental Medicine. 140: 797-811. PMID 4378413 DOI: 10.1084/Jem.140.3.797  0.311
1974 Cochrane CG, Revak SD, Wuepper KD, Johnston A, Morrison DC, Ulevitch R. Soluble mediators of injury of the microvasculature; Hageman factor and the kinin forming, intrinsic clotting and the fibrinolytic systems. Microvascular Research. 8: 112-121. PMID 4278273 DOI: 10.1016/0026-2862(74)90069-7  0.325
1974 Revak SD, Cochrane CG, Johnston AR, Hugli TE. Structural Changes Accompanying Enzymatic Activation of Human Hageman Factor Journal of Clinical Investigation. 54: 619-627. PMID 4277669 DOI: 10.1172/Jci107799  0.327
1973 Cochrane CG, Revak SD, Wuepper KD. Activation Of Hageman Factor In Solid And Fluid Phases A Critical Role Of Kallikrein Journal of Experimental Medicine. 138: 1564-1583. PMID 4271629 DOI: 10.1084/Jem.138.6.1564  0.343
1973 Benveniste J, Henson PM, Cochrane CG. Leukocyte-dependent histamine release from rabbit platelets. The role of IgE, basophils, and a platelet-activating factor. The Journal of Experimental Medicine. 136: 1356-77. PMID 4118412 DOI: 10.1084/Jem.136.6.1356  0.325
1972 Cochrane CG, Wuepper KD, Aiken BS, Revak SD, Spiegelberg HL. The Interaction of Hageman Factor and Immune Complexes Journal of Clinical Investigation. 51: 2736-2745. PMID 5056666 DOI: 10.1172/Jci107093  0.352
1972 DeShazo CV, Henson PM, Cochrane CG. Acute immunologic arthritis in rabbits. The Journal of Clinical Investigation. 51: 50-7. PMID 4257028 DOI: 10.1172/Jci106796  0.333
1971 Levine S, Cochrane CG, Carpenter CB, Behan PO. Allergic Encephalomyelitis: Effect of Complement Depletion with Cobra Venom Proceedings of the Society For Experimental Biology and Medicine. 138: 285-289. PMID 5001508 DOI: 10.3181/00379727-138-35880  0.3
1971 Henson PM, Cochrane CG. Acute immune complex disease in rabbits. The role of complement and of a leukocyte-dependent release of vasoactive amines from platelets. The Journal of Experimental Medicine. 133: 554-71. PMID 4106804 DOI: 10.1084/Jem.133.3.554  0.309
1971 Cochrane CG, Wuepper KD. The first component of the kinin-forming system in human and rabbit plasma. Its relationship to clotting factor XII (Hageman Factor). Journal of Experimental Medicine. 134: 986-1004. PMID 4106492 DOI: 10.1084/Jem.134.4.986  0.339
1971 Cochrane CG. Mechanisms involved in the deposition of immune complexes in tissues. Journal of Experimental Medicine. 134: 75-89. DOI: 10.1084/Jem.134.3.75  0.312
1969 Henson PM, Cochrane CG. Immunological induction of increased vascular permeability. I. A rabbit passive cutaneous anaphylactic reaction requiring complement, platelets, and neutrophils. The Journal of Experimental Medicine. 129: 153-65. PMID 5774114 DOI: 10.1084/Jem.129.1.153  0.32
1969 Henson PM, Cochrane CG. Immunological induction of increased vascular permeability. II. Two mechanisms of histamine release from rabbit platelets involving complement. The Journal of Experimental Medicine. 129: 167-84. PMID 4178112 DOI: 10.1084/Jem.129.1.167  0.321
1968 Kniker WT, Cochrane CG. The Localization Of Circulating Immune Complexes In Experimental Serum Sickness : The Role Of Vasoactive Amines And Hydrodynamic Forces Journal of Experimental Medicine. 127: 119-136. PMID 4864670 DOI: 10.1084/Jem.127.1.119  0.304
1968 Cochrane CG. Immunologic tissue injury mediated by neutrophilic leukocytes. Advances in Immunology. 9: 97-162. PMID 4236490 DOI: 10.1016/S0065-2776(08)60442-3  0.341
1965 Ward PA, Cochrane CG, Mueller-Eberhard HJ. The Role Of Serum Complement In Chemotaxis Of Leukocytes In Vitro Journal of Experimental Medicine. 122: 327-346. PMID 14316948 DOI: 10.1084/Jem.122.2.327  0.329
1965 Ward PA, Cochrane CG. Bound Complement And Immunologic Injury Of Blood Vessels Journal of Experimental Medicine. 121: 215-234. PMID 14264268 DOI: 10.1084/Jem.121.2.215  0.318
1963 Cochrane CG. Studies On The Localization Of Circulating Antigen-Antibody Complexes And Other Macromolecules In Vessels. Ii. Pathogenetic And Pharmacodynamic Studies. Journal of Experimental Medicine. 118: 503-513. PMID 14067902 DOI: 10.1084/Jem.118.4.503  0.313
1963 Cochrane CG. Studies On The Localization Of Circulating Antigen-Antibody Complexes And Other Macromolecules In Vessels. I. Structural Studies. Journal of Experimental Medicine. 118: 489-502. PMID 14067901 DOI: 10.1084/Jem.118.4.489  0.316
1963 Cochrane CG, Dixon FJ. Antibody Production by Transferred Cells1 Advances in Immunology. 2: 205-239. DOI: 10.1016/S0065-2776(08)60114-5  0.5
1958 Cochrane CG, Weigle WO. The cutaneous reaction to soluble antigen-antibody complexes; a comparison with the Arthus phenomenon. Journal of Experimental Medicine. 108: 591-604. PMID 13587844 DOI: 10.1084/Jem.108.5.591  0.316
Show low-probability matches.